Showing results (551-560 of 610) with videos related to
Sort By:
Pageof 61
Neuro-Oncology|April 4, 2020
Clinical impact of combined epigenetic and molecular analysis of pediatric low-grade gliomasKohei Fukuoka, Yasin Mamatjan, Ruth Tatevossian, et al.Medrxiv : the Preprint Server for Health Sciences|February 7, 2023
Germline pathogenic variants in 786 neuroblastoma patientsJung Kim, Zalman Vaksman, Laura E Egolf, et al.Nature Communications|August 27, 2021
Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivityS Y Cindy Yang, Scott C Lien, Ben X Wang, et al.Nature Genetics|October 11, 2016
The genomic landscape of schwannomaSameer Agnihotri, Shahrzad Jalali, Mark R Wilson, et al.Nature Communications|January 25, 2020
Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancerStanley Zhou, James R Hawley, Fraser Soares, et al.Cancer Discovery|October 1, 2013
Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumorsEsra A Akbay, Shohei Koyama, Julian Carretero, et al.Cell Genomics|February 13, 2023
CanDIG: Federated network across Canada for multi-omic and health data discovery and analysisL Jonathan Dursi, Zoltan Bozoky, Richard de Borja, et al.Journal of the National Cancer Institute|September 9, 2023
Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survivalJung Kim, Zalman Vaksman, Laura E Egolf, et al.Journal for Immunotherapy of Cancer|October 2, 2021
Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity studyMarc Oliva, Douglas Chepeha, Daniel V Araujo, et al.Genome Medicine|December 4, 2021
A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing geneCaitlin T Fierheller, Laure Guitton-Sert, Wejdan M Alenezi, et al.Pageof 61